Research and Development of Reading Visual Aids for Low-Vision Individuals Based on Virtual Reality Technology

July 12, 2026 updated by: Jinyuan,MD, Beijing Tongren Hospital

Illuminate Children's Reading World: Research and Development of Virtual Reality Reading Aids for Low-Vision Populations

Low vision substantially impairs reading ability and educational participation in adolescents. Existing assistive technologies, including optical magnifiers and electronic visual aids, are often limited by fragmented system architectures and insufficient support for multimodal cognitive processing.

This study aimed to develop and evaluate a virtual reality (VR)-based intelligent reading aid integrating image enhancement, optical character recognition (OCR), text-to-speech (TTS), and large language model (LLM)-based semantic summarization for low-vision users.

Study Overview

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510060
        • Specialized School for Visually Impaired Students in Guangdong Province

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Safety Evaluation Cohort Inclusion Criteria:

  • Healthy adult volunteers aged 18-40 years
  • Best-corrected binocular visual acuity of 0.8 or better
  • Stereopsis of 60 arcsec or better
  • Tear film break-up time of at least 10 seconds,Horizontal phoria within 15 prism diopters at both distance and near,Spherical equivalent refractive errors between plano and -6.00 D,Astigmatism not exceeding 3.00 D,Anisometropia not exceeding 2.00 D
  • Intraocular pressure between 10 and 21 mmHg
  • All participants provided written informed consent before enrollment

Exclusion Criteria:

  • Any current or previous organic ocular disease (such as keratitis, glaucoma, or retinal detachment)
  • Previous ophthalmic surgery (including refractive surgery or vitreoretinal surgery)
  • Systemic or psychiatric disorders that could affect study participation
  • Inability or unwillingness to complete the examination procedures

Functional Evaluation Cohort:

Inclusion Criteria:

  • Aged 9-17 years
  • Clinically diagnosed with visual impairment, meeting the inclusion criteria for low vision or severe visual impairment
  • Sufficient basic reading ability to complete the experimental tasks
  • Written informed consent obtained from all participants and their legal guardians prior to participation

Exclusion Criteria:

  • Systemic or psychiatric disorders affecting participation
  • Inability or unwillingness to complete the examination procedures Functional Evaluation Cohort

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Baseline: Unaided Reading
Arm Name:Unaided Reading (Baseline) Arm Type:Active Comparator Intervention Type:Device Intervention Name:Natural Vision Reading (No Assistive Device) Intervention Description: Participants complete standardized Chinese reading tasks relying on natural vision without any visual aid. Each task contains 100 Chinese characters. Reading performance and user satisfaction are evaluated.

Intervention Description: Participants use the VR head-mounted intelligent reading aid to complete the same standardized reading tasks. The device integrates image enhancement, OCR, text-to-speech (TTS) and LLM-based semantic summarization. The test luminance is set at 400 nit (maximum recommended brightness). Each task contains 100 Chinese characters.

Duration:Single session, approximately 5 minutes

Experimental: Experimental: VR-Assisted Reading

Arm Name:VR-Based Intelligent Reading Aid Arm Type:Experimental Intervention Type:Device Intervention Name:VR-Based Multimodal Intelligent Reading Aid (Langshiqing Low-Vision Device) Intervention Description: Participants use the VR head-mounted intelligent reading aid to complete the same standardized reading tasks. The device integrates image enhancement, OCR, text-to-speech (TTS) and LLM-based semantic summarization. The test luminance is set at 400 nit (maximum recommended brightness). Each task contains 100 Chinese characters.

Duration:Single session, approximately 5 minutes

Participants complete reading tasks with natural vision, without using any assistive device.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Phoria
Time Frame: within 10 minutes after all reading tasks
Variation of ocular phoria before and after single-session VR intelligent reading aid use, to evaluate the impact of near-eye VR optical system on adult eye position stability.
within 10 minutes after all reading tasks
Reading Completion Time
Time Frame: within 10 minutes after all reading tasks
Time to finish standardized 100-character Chinese reading tasks (unit: second). Compare results between unaided and VR-assisted conditions.
within 10 minutes after all reading tasks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tear Break-Up Time (TBUT)
Time Frame: within 10 minutes after all reading tasks
Change in tear break-up time before and after VR device use for assessment of ocular surface dryness in adult participants.
within 10 minutes after all reading tasks
Accommodative Function
Time Frame: within 10 minutes after all reading tasks
Alteration of eye accommodative function after using the VR reading aid among adult subjects.
within 10 minutes after all reading tasks
Simulator Sickness Questionnaire (SSQ)
Time Frame: within 10 minutes after all reading tasks

Scale Description:The SSQ is a self-report questionnaire that assesses VR-related simulator sickness. Each item is rated on a 4-point scale: None (0), Slight (1), Moderate (2), and Severe (3). Through weighted calculations, four scores are derived: Nausea-related subscore (N), Oculomotor-related subscore (O), Disorientation-related subscore (D), and Total Score (TS).

Minimum and Maximum Values:

  • ndividual items: 0 (None) to 3 (Severe)
  • Total Score (TS): 0 to 235.62 (based on standard weighted scoring)
  • Nausea subscore (N): 0 to 200.34
  • Oculomotor subscore (O): 0 to 200.34
  • Disorientation subscore (D): 0 to 292.32 Interpretation:Higher scores indicate worse outcomes (more severe simulator sickness/cybersickness).
within 10 minutes after all reading tasks
Best-Corrected Visual Acuity (BCVA)
Time Frame: within 10 minutes after all reading tasks
Change in best-corrected visual acuity before and after VR reading session for adult low-vision users.
within 10 minutes after all reading tasks
Intraocular Pressure (IOP)
Time Frame: within 10 minutes after all reading tasks
Fluctuation of intraocular pressure pre and post VR device reading task in adult participants.
within 10 minutes after all reading tasks
User Satisfaction Score
Time Frame: within 10 minutes after all reading tasks
100-point satisfaction scale. VR group includes four sub-items: magnification, text-to-speech, OCR and AI summarization (25 points each).
within 10 minutes after all reading tasks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2024

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

June 15, 2026

First Submitted That Met QC Criteria

July 12, 2026

First Posted (Actual)

July 14, 2026

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 12, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2024LSPJ164

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Vision in Children

Clinical Trials on VR-Based Intelligent Reading Aid

3
Subscribe